Brunner, M <br/><br/>
Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Feb 2003 
 - 395-402 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.2003.01445.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Delayed-Action Preparations<br/>Gastrointestinal Transit--physiology<br/>Humans<br/>Intestinal Absorption--physiology<br/>Male<br/>Mesalamine--administration & dosage<br/>Tablets